MTOR and cancer: The results revealed that GCP targets and reduces the activities of CDK1 and PLK1, thereby suppressing cell proliferation, inducing cell cycle arrest in G2/M phase, promoting cancer cell apoptosis via the intrinsic mitochondrial pathway, and inducing autophagy via the PI3K/AKT/mTOR signaling pathway.